about
Hereditary hemochromatosis in the post-HFE eraIron-overload-related disease in HFE hereditary hemochromatosisScreening for HFE and iron overloadAssociation between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver diseaseEvaluation of Different Normalization and Analysis Procedures for Illumina Gene Expression Microarray Data Involving Small Changes.Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population.Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjects.Hepatitis C and iron.Iron uptake from plasma transferrin by the duodenum is impaired in the Hfe knockout mouse.HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis.Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.Serum iron markers are inadequate for guiding iron repletion in chronic kidney diseaseHigh prevalence of coeliac disease in a population-based study from Western Australia: a case for screening?Diagnostic performance of a rapid magnetic resonance imaging method of measuring hepatic steatosis.Molecular pathogenesis of iron overload.Dietary iron enhances colonic inflammation and IL-6/IL-11-Stat3 signaling promoting colonic tumor development in mice.Oval cell-mediated liver regeneration: Role of cytokines and growth factors.Upregulation of lymphotoxin beta expression in liver progenitor (oval) cells in chronic hepatitis C.Screening for hemochromatosis: patients with liver disease, families, and populations.Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction.Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)Stereological Analysis of Liver Biopsy Histology Sections as a Reference Standard for Validating Non-Invasive Liver Fat Fraction Measurements by MRIIron overload.Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study.Prevalence, characteristics, and prognostic significance of HFE gene mutations in type 2 diabetes: the Fremantle Diabetes Study.Outcomes for women in a flexible sigmoidoscopy-based colorectal cancer screening programme.Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases.HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity.HFE C282Y homozygotes are at increased risk of breast and colorectal cancerBrain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features.A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis.Reasons for noncompliance with five-yearly screening flexible sigmoidoscopyScreening for coeliac disease using anti-tissue transglutaminase antibody assays, and prevalence of the disease in an Australian community.TWEAK and LTβ Signaling during Chronic Liver Disease.A cross-sectional community study of serum iron measures and cognitive status in older adults.Phenotypic expression of hereditary hemochromatosis: what have we learned from the population studies?Clinical penetrance of C282Y homozygous HFE hemochromatosis.Characteristics of the arthropathy described in hereditary hemochromatosis.Natural history and management of HFE-hemochromatosis.Gastric intraepithelial neoplasia in a Western population.
P50
Q24646056-4B283E7B-CEF1-4259-86AB-BB6F2F624A69Q28264901-7F3A66BF-62EA-45E2-A506-A3A0354B2F0DQ28284219-0491F553-6115-4999-92C6-94E94E167BE2Q28943559-3B6EC70D-5A09-4200-9D90-C92EF2BA2549Q31127418-D9AE836D-0F44-4EFE-B4BE-613F59FB94B8Q31835547-8AD42DB2-F567-47D6-89F4-64B5CE77C5DCQ33520610-C1A20F80-C5F5-4C08-9A2C-0C95CB2B1A26Q33759861-28CBA70A-8110-4FAF-B081-E1FB75D994EBQ34025772-D2BDC81F-BE6B-4316-8996-B73DE6C7875FQ34101222-309683A7-C9FA-4F63-B4F9-8AFE6603F6BBQ34333701-0CD1B704-7C82-42F7-AC89-D7035443F4E8Q34497292-5CC44D5C-14D2-4B11-A334-7FE552C996BDQ34518132-7BDD1CCE-00C2-48AD-9A58-A84B050220BFQ34651049-70A03F7A-F7E7-405E-A778-7FFD5DD0E240Q34739178-9FB35FAD-425D-48F0-A360-611615949FFDQ35040244-6B5305C2-5B68-41C8-ADC2-C83C001D402DQ35041643-0F455039-630B-4990-8083-DC4C18ECA870Q35595996-DC2EF6F5-8F74-44C7-98F9-0E39D2E907B0Q35628117-F2720264-FDE3-4C8E-9840-49340FCDA806Q35763769-2A98C6BF-82C6-4C85-B878-58F58D515810Q35960098-D2C01174-798D-4D1E-9744-2633C436842DQ36097591-A0642B2B-BB64-49A3-BB3D-CFF31AFFC536Q36122907-B273BE21-64BD-43D8-8D87-6DB901E91C85Q36663501-4BB32C17-74CE-4647-9606-5C8123A1FE88Q36842036-8C631F7D-20D6-4CBE-99C2-D01154F1770BQ36960634-6C8ADFA7-8110-4CD0-AE9E-14F37C646160Q37127064-FF33C626-C892-4D02-BCAB-68A7D3D3CA16Q37149526-71232BB6-E595-4AF4-A04A-F89DEFADF1AEQ37274209-C94891A3-2F38-4431-A975-062B8FB04DECQ37364099-2D78F962-E29E-4714-91D4-A24A0E984365Q37399509-38EAE1F3-378F-43A3-BFFE-E7974F1EC76CQ37405585-2D6A1BA5-7047-468F-9B6C-AE3FAF6874BCQ37449080-C2D033E3-1D67-443C-A41F-C7C762E1DFF5Q37581555-91B41D38-C96F-468F-8125-0ECA85957960Q37698099-3685B627-8339-4F2C-9B8C-B71CF0F19EBDQ37738631-E2075448-E1EF-40E6-B916-877054A3FEADQ37810066-FAA56F6F-6058-490A-AFC4-33A2D9DCD368Q37876385-7BE62202-8BC9-46E6-9F04-7034BFAC4B5AQ37929070-D7921199-2DC6-4D36-A827-9910C78DB8F3Q37955780-7A9D056C-8F46-4723-95EA-992CAC342678
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John K Olynyk
@nl
John K Olynyk
@sl
John K. Olynyk
@en
John K. Olynyk
@es
type
label
John K Olynyk
@nl
John K Olynyk
@sl
John K. Olynyk
@en
John K. Olynyk
@es
prefLabel
John K Olynyk
@nl
John K Olynyk
@sl
John K. Olynyk
@en
John K. Olynyk
@es
P108
P106
P108
P1153
7005942097
P21
P31
P496
0000-0003-0417-3411